HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,4-dihydroselenoquinazoline

has antineoplastic activity; structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinazolines: 402
      - 2,4-dihydroselenoquinazoline: 1
Organic Chemicals: 133
- Organoselenium Compounds: 63
  - 2,4-dihydroselenoquinazoline: 1

Experts

1.	Doughty-Shenton, Dahlia: 1 article (10/2014)
2.	Encío, Ignacio: 1 article (10/2014)
3.	Font, María: 1 article (10/2014)
4.	Moreno, Esther: 1 article (10/2014)
5.	Palop, Juan Antonio: 1 article (10/2014)
6.	Plano, Daniel: 1 article (10/2014)
7.	Sanmartín, Carmen: 1 article (10/2014)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 10/15/2014 - "In this study, we found that the seleno-compound 2,4-dihydroselenoquinazoline (3a) generally inhibited this signalling axis in MCF-7 breast cancer cells and caused downregulation of S6 ribosomal protein phosphorylation in a dose- and time-dependent manner. "

Related Drugs and Biologics

1.	Ribosomal Proteins (Ribosomal Protein)